Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients

Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00134108

Enrollment

Unknown

Registered

2005-08-24

Start date

2003-01-31

Completion date

2005-12-31

Last updated

2005-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Cancer

Brief summary

The purpose of this study is to conduct a formal controlled evaluation of the potential benefits of CBT for insomnia in cancer patients.

Interventions

BEHAVIORALCognitive Behaviour Therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Meets clinical criteria for insomnia. * Diagnosis of breast, prostate, colorectal or gynaecological cancer. * In follow-up phase with no further anti-cancer therapy planned.

Exclusion criteria

* Anti-cancer chemotherapy or radiotherapy within 4 weeks of trial entry. * Evidence of sleep apnoea or other sleep disorder. * Evidence of untreated major depressive disorder.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026